医学事务

The effective practice of medical affairs is essential for the generation and communication of relevant evidence to a broad range of stakeholders across the healthcare environment. While fulfilling a pivotal function in its own right, strategically aligned medical affairs powerfully enhances market access and commercial activities by laying a strong foundation of scientific understanding on which to create value for the product, health care professionals and patients.

医学事务

我们的方法

Costello Medical 经验丰富的医学事务团队致力于追求科学的严谨性，并为客户量身定制项目交付方案。我们擅长就医学信息的战略性规划、设计、开发、传播和教育等提供支持，并提供技术见解和创造性解决方案

提升客户的科学声誉
提升客户的科学声誉

我们的团队具备卓越的专业技能与出色的外部沟通能力，能够促进各方之间的协作交流

严谨的科学与创新的思维相融合
严谨的科学与创新的思维相融合

我们经验丰富的医学撰稿人与才华横溢的内部设计师通力合作，将复杂的医学数据以创新形式呈现，从而促进受众对 “产品背后科学” 的理解

长期稳定的合作伙伴关系
长期稳定的合作伙伴关系

我们将医学专业技能、对项目的高度关注、对工作的灵活应对能力和有问必答的精神有机结合，以满足客户不断变化的需求

诚信透明的运作方式
诚信透明的运作方式

科学的严谨性、完整性和透明度对我们至关重要，因此我们密切关注并实践日益发展的行业行为准则，以确保所有项目工作均符合医学行业合规监管要求

我们的专业团队在下列项目中有丰富的经验：

专家咨询会和临床试验研究者会议

战略性医学事务规划和实施

多渠道医学教育，包括培训资料准备和活动现场支持

医学信息资料和标准应答文件 (SRDs)

会议筹备与展会材料准备

学术会议总结报告

Costello Medical are experienced in working closely with clients to ensure all projects are delivered in adherence to industry-standards and client-specific compliance principles

Experts in using content management and approval platforms. We are also a “Veeva Content Partner”, which allows for an unlimited number of Veeva Vault PromoMats Review and Approval licences and access to the most up-to-date Veeva training and support.

Veeva Logo
Arts Logo

Experienced in compliance principles. We are Compliance Hub ARTS Members, which includes annual ABPI Code of Practice training days, an on-demand consulting service (covering European codes of practice also), and monthly email reports on case studies of recent breaches.

如果您想了解项目报价或更多详情，请联系 Ma Qian 马茜

案例展示

在高度竞争的环境中为扩大药品上市许可范围提供长期支持

The vision was to expand a product’s marketing license into a new and challenging patient subpopulation facing a high degree of unmet need, spanning multiple indications and specialties.

We comprehensively supported a spectrum of medical activities over a 2-year period around the label change. Consistent support from a core team ensured clinical insights and technical knowledge gained at each stage were built upon as the overall strategy evolved and tactics delivered. Furthermore, our collaborative in-house approach brought in technical expertise from other specialist teams across Costello Medical to optimise related projects, offering joined-up support to achieve the long-term goal.

Targeted literature reviews performed in collaboration with our evidence development team identified existing gaps in treatment management and evidence for the current unmet need for this specific patient subpopulation. These findings informed the overall strategic objectives and laid the foundations for the communication plan.

Engaged international experts through advisory board meetings to closely examine and interrogate the supporting clinical data. Resulting insights fed into the development and testing of a scientifically robust and compelling narrative for the value of the product in this patient group.

Comprehensive and engaging internal training programmes were designed, developed and deployed in close partnership with our in-house design team. Engaging eLearning modules, interactive slide kits, training events and assessments equipped medical field teams with the technical knowledge required to speak with accuracy and consistency around the science behind the label change.

Targeted multichannel medical and educational activities, events and tools deployed to engage external stakeholders around the license expansion. These spanned educational webinars and symposia, standard-response documents and interactive slide kits. Close collaboration with our publications team enabled us to fast-track communications based on pivotal publications. All activities involved a critical attention to compliance.

Post regulatory change, the collaboration deepened to include scientific, training and technical support of the commercial and market access teams and activities driving global product re-positioning. Our effective long-term partnership with multilevel medical support helped achieve the expansion of a product’s license to serve more patients.

Explore our process

Targeted literature reviews performed in collaboration with our evidence development team identified existing gaps in treatment management and evidence for the current unmet need for this specific patient subpopulation. These findings informed the overall strategic objectives and laid the foundations for the communication plan.

Engaged international experts through advisory board meetings to closely examine and interrogate the supporting clinical data. Resulting insights fed into the development and testing of a scientifically robust and compelling narrative for the value of the product in this patient group.

Comprehensive and engaging internal training programmes were designed, developed and deployed in close partnership with our in-house design team. Engaging eLearning modules, interactive slide kits, training events and assessments equipped medical field teams with the technical knowledge required to speak with accuracy and consistency around the science behind the label change.

Targeted multichannel medical and educational activities, events and tools deployed to engage external stakeholders around the license expansion. These spanned educational webinars and symposia, standard-response documents and interactive slide kits. Close collaboration with our publications team enabled us to fast-track communications based on pivotal publications. All activities involved a critical attention to compliance.

Post regulatory change, the collaboration deepened to include scientific, training and technical support of the commercial and market access teams and activities driving global product re-positioning. Our effective long-term partnership with multilevel medical support helped achieve the expansion of a product’s license to serve more patients.

Loading